Apollo Silver Corp. ("Apollo Silver" or the "Company") (TSX.V:APGO, OTCQB:APGOF, Frankfurt:6ZF) is pleased to announce that, ...

Central Chidlom has firmly established itself as a luxury flagship under the identity "The Store of Bangkok." It has become a ...

How to Rank 1st in AI Search POST FALLS, IDAHO / ACCESS Newswire / December 18, 2025 / Trustpoint Xposure has released a new executive-level ebook designed to help organizations rank as the cited answ ...

VANCOUVER, BC / ACCESS Newswire / December 18, 2025 / Sun Peak Metals Corp. (TSXV:PEAK)(OTCQB:SUNPF) ("Sun Peak" or the "Company") is pleased to announce the successful completion of its previously an ...

Achieves another quarter of higher-than-expected revenue and profitability and hits the top-end of cash flow guidanceQNX division achieves highest revenue quarter everSecure Communications division be ...

MINNEAPOLIS, MN / ACCESS Newswire / December 18, 2025 / Air T, Inc. (NASDAQ:AIRT) is pleased to announce the successful closing of its acquisition of Regional Express Holdings Limited (Rex), Australia ...

MURFREESBORO, TN / ACCESS Newswire / December 18, 2025 / National Health Investors, Inc. (NYSE:NHI) announced today that it has invested $89.2 million, including transaction costs, in four separate tr ...

Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in diagnostic and prognostic innovation through advanced ...

Air Lease (NYSE: AL) announced today that its Class A common stockholders have voted to approve the previously announced definitive merger agreement, dated as of September 1, 2025, pursuant to which ...

Bridgeline Digital, Inc. (NASDAQ:BLIN), a leader in AI-powered marketing technology, today announced financial results for its fiscal 2025 ...

SUNNYVALE, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) -- eGain Corporation (NASDAQ: EGAN), the leading AI knowledge platform for customer experience, today announced that Achmea, one of Europe's largest c ...

Phase 1 trial in aggressive brain cancer (Glioblastoma) is the first clinical trial of uTREAT belonging to Curasight's treatment platformNo patient safety issues were reported The dosing marks ...